Loading clinical trials...
Loading clinical trials...
A Randomized, Double-blind, Dose-adjustment, Placebo-controlled Study to Evaluate the Efficacy and Safety of Aripiprazole in Children and Adolescents With Chronic Tic Disorders or Tourette's Disorder
Conditions
Interventions
aripiprazole
placebo
Locations
6
South Korea
Inha University Hospital
Inchon, South Korea
Seoul National University Hospital
Seoul, South Korea
Yonsei University Severance Hospital
Seoul, South Korea
Samsung Medical Center
Seoul, South Korea
Asan Medical Center
Seoul, South Korea
Chung-Ang Univ. Medical center
Seoul, South Korea
Start Date
October 1, 2008
Primary Completion Date
April 1, 2010
Completion Date
April 1, 2010
Last Updated
July 26, 2013
NCT01418339
NCT02864589
NCT01585207
NCT01727713
Lead Sponsor
Korea Otsuka Pharmaceutical Co., Ltd.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions